K251610 is an FDA 510(k) clearance for the qER-CTA (v1.0). Classified as Radiological Computer-assisted Triage And Notification Software (product code QAS), Class II - Special Controls.
Submitted by Qure.Ai Technologies (Mumbai, IN). The FDA issued a Cleared decision on September 8, 2025 after a review of 104 days - within the typical 510(k) review window.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2080 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.
View all Qure.Ai Technologies devices